鶹ýɫƬ

Journal News

Butter, olive oil, coconut oil — what to choose?

Seema Nath
May 28, 2025

Olive, vegetable, canola, avocado, coconut, sunflower seed, almond and many other types of oil line the shelves of most grocery stores in the U.S. Deciding on the appropriate option while facing varying price tags and nutritional facts can be daunting.

To help make the choice easier, , a research associate, and his team at the University of Cambridge analyzed how various types of dietary fats may impact the health of adults. They published their in the Journal of Lipid Research.

Daniela Malide, National Heart, Lung and Blood Institute/NIH
Murine adipocytes, shown in red, innervated by blood vessels, shown in green.

The health effects of saturated fats, or SFs, may be determined by their chain length and the number of carbon atoms, based on studies that examined the association between plasma fatty acids, or FAs, and the risk of cardiometabolic diseases. For example, plasma SFs with an odd number of carbon atoms are associated with lower risks of type 2 diabetes and cardiovascular disease, or CVD, risk. Conversely, common SFs with an even number of carbon atoms show potential associations with higher risks of type 2 diabetes and CVDs.

“We do know these associations exist, but what we are not sure about is how intakes of different dietary fats impact the concentrations of circulating FAs,” Sowah said.

Different dietary fats contain varied amounts of individual FAs. Comparative studies on how common dietary fats affect blood levels of a variety of FAs — especially odd-chain saturated and trans FAs — are limited. In addition, existing observational studies are often confounded by inaccuracies in self-reported dietary intake.

“We set out to investigate the effects of intake of coconut oil, olive oil or butter fats on plasma FAs,” Sowah said. The team also assessed the association between the changes in major plasma FAs and changes in metabolic markers such as plasma lipids.

The researchers used gas chromatography to measure plasma concentrations of 37 different phospholipid FAs in 96 adults before and after they consumed equal amounts of coconut oil, olive oil or butter for four weeks.

The researchers found that equal amounts of different fat sources altered plasma phospholipid FA concentrations in distinct ways. Coconut oil consumption doubled levels of medium-chain saturated FAs with 12 and 14 carbon atoms, while butter increased odd-chain saturated FAs containing 15 and 17 carbon atoms — an effect not seen with coconut or olive oil. Olive oil led to the greatest rise in oleic acid, a fat commonly found in olives, while coconut oil decreased it. Linoleic acid, which was highest in olive oil compared to coconut oil and butter, did not rise significantly in the olive oil group but did increase in those who consumed coconut oil, though the reason remains unclear.

Despite these changes in blood FA profiles, the study found no strong associations between changes in plasma FAs and shifts in metabolic markers. However, two subtle patterns emerged: higher plasma oleic acid levels were linked to lower high-density lipoprotein, or good cholesterol, and slightly elevated cholesterol markers, while increased trans fats from butter correlated with higher low-density lipoprotein, or bad cholesterol, and triglycerides.

These findings highlight how different dietary fats uniquely influence blood FAs profiles and potentially subsequent risk of cardiometabolic disease and suggest that choosing fats like olive oil, which are lower in saturated and trans fats, may be a heart-healthier option over time.

According to Sowah, they could not distinguish slightly different typesof plasma trans FAs, highlighting the need for advanced chromatography techniques. Future long-term studies with larger sample sizes and varying fat doses will help clarify how specific dietary fats affect blood FA profiles and subsequent cardiometabolic disease risk.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Seema Nath

Seema Nath is a postdoctoral research fellow at the University of Texas Health Science Center at San Antonio. She is an ASBMB volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.